Literature DB >> 21076066

CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection.

Laura M Snell1, Ann J McPherson, Gloria H Y Lin, Shimon Sakaguchi, Pier Paolo Pandolfi, Carlo Riccardi, Tania H Watts.   

Abstract

The regulation of T cell expansion by TNFR family members plays an important role in determining the magnitude of the immune response to pathogens. As several members of the TNFR family, including glucocorticoid-induced TNFR-related protein (GITR), are found on both regulatory and effector T cells, there is much interest in understanding how their effects on these opposing arms of the immune system affect disease outcome. Whereas much work has focused on the role of GITR on regulatory T cells, little is known about its intrinsic role on effector T cells in an infectious disease context. In this study, we demonstrate that GITR signaling on CD8 T cells leads to TNFR-associated factor (TRAF) 2/5-dependent, TRAF1-independent NF-κB induction, resulting in increased Bcl-x(L). In vivo, GITR on CD8 T cells has a profound effect on CD8 T cell expansion, via effects on T cell survival. Moreover, GITR is required on CD8 T cells for enhancement of influenza-specific CD8 T cell expansion upon administration of agonistic anti-GITR Ab, DTA-1. Remarkably, CD8 T cell-intrinsic GITR is essential for mouse survival during severe, but dispensable during mild respiratory influenza infection. These studies highlight the importance of GITR as a CD8 T cell costimulator during acute viral infection, and argue that despite the similarity among several TNFR family members in inducing T lymphocyte survival, they clearly have nonredundant functions in protection from severe infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076066     DOI: 10.4049/jimmunol.1001912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.

Authors:  Ann J McPherson; Laura M Snell; Tak W Mak; Tania H Watts
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

Review 2.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 3.  Modulation of GITR for cancer immunotherapy.

Authors:  David A Schaer; Judith T Murphy; Jedd D Wolchok
Journal:  Curr Opin Immunol       Date:  2012-01-12       Impact factor: 7.486

4.  GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.

Authors:  David A Schaer; Sadna Budhu; Cailian Liu; Campbell Bryson; Nicole Malandro; Adam Cohen; Hong Zhong; Xia Yang; Alan N Houghton; Taha Merghoub; Jedd D Wolchok
Journal:  Cancer Immunol Res       Date:  2013-11       Impact factor: 11.151

Review 5.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

6.  CD27 Promotes CD4+ Effector T Cell Survival in Response to Tissue Self-Antigen.

Authors:  Kelly A Remedios; Lauren Meyer; Bahar Zirak; Mariela L Pauli; Hong-An Truong; Devi Boda; Michael D Rosenblum
Journal:  J Immunol       Date:  2019-06-17       Impact factor: 5.422

Review 7.  TRAF family molecules in T cells: Multiple receptors and functions.

Authors:  Tina Arkee; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2019-11-21       Impact factor: 4.962

Review 8.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

Review 9.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation.

Authors:  Sun-Young Chang; Joo-Hye Song; Bayasi Guleng; Carmen Alonso Cotoner; Seiji Arihiro; Yun Zhao; Hao-Sen Chiang; Michael O'Keeffe; Gongxian Liao; Christopher L Karp; Mi-Na Kweon; Arlene H Sharpe; Atul Bhan; Cox Terhorst; Hans-Christian Reinecker
Journal:  Immunity       Date:  2012-12-13       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.